The Patent Finder
PM

Prime Merger Sub, LLC

First filing 2013
OverviewNotableFeesChangesFamiliesPatent listSources & methods

18 patents currently held

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
1 more record may belong here and awaits a decision; it is not counted.

The next term ends in Sep 2031. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Sep 2031
Next term end
9
Patent families

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
notable patents all others Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jun 30, 2027
    The maintenance fee for Expandable Amnion Membrane for Treating Non-Healing Wounds (US 10,517,902) comes due Jun 30, 2027. Unpaid by Jan 3, 2028, it lapses early.
  • 1 fee due Aug 13, 2027
    The maintenance fee for Visco-Supplement Compositions, and Methods of Use Thereof (US 11,896,623) comes due Aug 13, 2027. Unpaid by Feb 14, 2028, it lapses early.
  • 1 fee due Sep 3, 2027
    The maintenance fee for Methods of Treating Joint Diseases, Disorders, and Conditions with Tissue Inhibitors of Matrix Metalloproteinases (US 10,576,107) comes due Sep 3, 2027. Unpaid by Mar 3, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

What they patent

The 5 largest of its 9 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.
PatentTitleStatusExpiresConfidence
US 10,517,902Expandable Amnion Membrane for Treating Non-Healing Wounds
In force
 · Medium confidence
In forceMedium confidence
US 9,486,316Osteoconductive Implants and Methods of Using Same
In force
 · High confidence
In forceHigh confidence
US 9,539,104Osteoconductive Implants and Methods of Using Same
In force
 · High confidence
In forceHigh confidence
US 9,616,093Placental Membrane Preparation and Methods of Making and Using Same
In force
 · Medium confidence
In forceMedium confidence
US 9,511,119Preparations Containing Hepatocyte Growth Factor and Hyaluronic Acid and Methods of Making and Using Same
In force
 · High confidence
In forceHigh confidence
US 10,279,075Preparations Containing Hepatocyte Growth Factor and Hyaluronic Acid, and Methods of Making and Using Same
In force
 · Low confidence
In forceLow confidence
US 9,700,585Multipotent Prenatal Stem Cells
In force
 · High confidence
In forceHigh confidence
US 12,150,445Method and Composition for Hypothermic Storage of Placental Tissue
In force
 · High confidence
In forceHigh confidence
US 11,083,758Placental Membrane Preparations and Methods of Making and Using Same for Regenerating Cartilage and Spinal Intervertebral Discs
In force
 · High confidence
In forceHigh confidence
US 12,501,893Method and Composition for Hypothermic Storage of Placental Tissue
In force
 · Medium confidence
In forceMedium confidence
10 of 18 patents shown.
Pro members see all 18.
Pro members: see all 18 patents
Also on record, not counted in the 18: 4 applications pending · 7 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited